EINDHOVEN, the Netherlands & LAUSANNE, Switzerland--(BUSINESS WIRE)--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces it has completed enrollment in the Up-LIFT study, a pivotal trial to evaluate the safety and effectiveness of ARC Therapy to restore hand and arm function in people with spinal cord injury (SCI). Up-LIFT is the first large-scale pivotal trial of non-invasive spinal cord stimulation technology.
ONWARD has now reached the studys enrollment ceiling of 65 subjects, enrolled at 14 leading SCI research sites throughout the United States, Canada, the United Kingdom, and the Netherlands. The Up-LIFT Study is a prospective, single-arm study designed to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARC Therapy) to treat upper extremity functional deficits in people with chronic tetraplegia.
The study reached its enrollment objective in under 12 months despite lock-downs, travel restrictions, and other COVID-related challenges, said Dave Marver, Chief Executive Officer of ONWARD. This milestone underscores the SCI communitys enthusiasm for this promising therapy. We will now work with determination to prepare submissions to regulatory authorities in the US and Europe so we can bring this important therapy to market for the benefit of people with SCI and their loved ones.
For individuals with impaired arm and hand function due to spinal cord injury, improved hand function directly translates into meaningful gains in terms of quality of life - being able to eat, dress or perform other daily life activities, said Edelle Field-Fote, PT, PhD, FAPTA, FASIA, co-PI of the Up-LIFT trial and Director of Spinal Cord Injury Research at Shepherd Center and Professor of Rehabilitation Medicine at Emory University School of Medicine. It was very rewarding to take part in this important trial and collaborate with many of the most highly respected SCI rehabilitation centers across the globe.
The end of enrollment for this trial marks a significant milestone in bringing non-invasive stimulation for restoring hand and arm function to people living with spinal cord injury said Chet Moritz, PhD, co-PI of the Up-LIFT trial and Associate Professor in the Departments of Electrical & Computer Engineering and Rehabilitation Medicine at the University of Washington in Seattle. We are hopeful this study can lead to the broad availability of this important therapy.
The company expects to initially commercialize ARC Therapy in the US, Germany, France, UK, Switzerland, and the Netherlands. To learn more about ONWARDs ARC Therapy and the companys vision to restore movement, independence and health in people with spinal cord injury, please visit ONWD.com.
About ONWARD
ONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury. ONWARDs work builds on more than a decade of basic science and preclinical research conducted at the worlds leading neuroscience laboratories. ONWARDs ARC Therapy, which can be delivered by implantable (ARCIM) or external (ARCEX) systems, is designed to deliver targeted, programmed stimulation of the spinal cord to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life. ONWARD has received three Breakthrough Device Designations from the FDA encompassing both ARCIM and ARCEX. The companys first FDA pivotal trial, called Up-LIFT, commenced in January 2021 and has now completed enrollment with 65 subjects worldwide.
ONWARD is headquartered at the High Tech Campus in Eindhoven, the Netherlands. It maintains an office at the EPFL Innovation Park in Lausanne, Switzerland and has a growing U.S. presence in Boston, Massachusetts, USA. For additional information about the company, please visit ONWD.com.
About Dr. Edelle Field-Fote
Dr. Edelle Field-Fote has a 20+ years of SCI research, building on her clinical background as a physical therapist and Ph.D. training in an animal model of SCI. Her contributions to SCI literature include the largest study to date of locomotor training for persons with chronic, motor-incomplete SCI, as well as the first-ever study of a rehabilitation intervention to promote neuroplasticity for improved hand function in persons with tetraplegia. Dr. Field-Fotes research has been funded by the National Institutes of Health (NIH) since 1997, and also by the National Institute on Independent Living, Disability and Rehabilitation Research (NILDRR) and the Department of Defense (DoD). Dr. Field-Fote is the editor/author of the textbook Spinal Cord Injury Rehabilitation (FA Davis Publishers).
About Dr. Chet Moritz
Dr. Chet Moritz is Associate Professor in the departments of Electrical & Computer Engineering, Rehabilitation Medicine, and Physiology & Biophysics at University of Washington, Seatlle. He was named an Allen Distinguished Investigator and appointed to the Christopher & Dana Reeve International Consortium on Spinal Cord Repair. Chet serves as the Co-Director for the Center for Neurotechnology, an NSF Engineering Research Center (ERC). Chet directs the Restorative Technologies Laboratory (RTL) which focuses on developing technologies to treat paralysis due to spinal cord injury. Current research in the lab includes a multi-site clinical trial of spinal stimulation to restore hand function for people with spinal cord injury, stimulation to improve walking for children with cerebral palsy, and optogenetic stimulation to guide neuroplasticity and recovery in the injured spinal cord of animals.
Disclaimer
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company or, as appropriate, the Company directors current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such persons officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.
Visit link:
- Opinion | The Fight for Your Kids' Brains Has Already Begun - The New York Times - September 9th, 2023 [September 9th, 2023]
- DEFENDING THE BRAIN | Duke Mag - Duke University - September 9th, 2023 [September 9th, 2023]
- The Innovations and Success of Elon Musk - OPP.Today - September 9th, 2023 [September 9th, 2023]
- Top Companies Using AI to Transform the Healthcare Industry ... - Cryptopolitan - September 9th, 2023 [September 9th, 2023]
- UN Warns Unregulated Neurotechnology Threatens 'Freedom of Thought' - Yahoo News - July 23rd, 2023 [July 23rd, 2023]
- I felt like there was someone in my head, and it wasn't me. - UNESCO - July 23rd, 2023 [July 23rd, 2023]
- Unraveling Connections Between the Brain and Gut - The Good Men Project - July 23rd, 2023 [July 23rd, 2023]
- Neurotechnology: what it is, applications - Iberdrola - February 10th, 2023 [February 10th, 2023]
- Forget Media Manipulation And Misinformation via TikTok And Twitter, Neurotechnology Heralds The New Battle For Our Brains - Forbes - February 10th, 2023 [February 10th, 2023]
- The Jacob Laboratory Translational Neurotechnology - January 2nd, 2023 [January 2nd, 2023]
- Massachusetts Institute Of Technology Experts Come Together In A Play Inspired By Advances In Neurotechnology - India Education Diary - January 2nd, 2023 [January 2nd, 2023]
- Neurotechnologies: The Next Technology Frontier | IEEE Brain - December 18th, 2022 [December 18th, 2022]
- Twelve Neurotechnology Startups to Present at 2022 Neurotech Leaders ... - November 19th, 2022 [November 19th, 2022]
- Research Experience for Undergraduates | Center for Neurotechnology - November 8th, 2022 [November 8th, 2022]
- Axoft Launches Brain Implant Technology to Treat Long-Term Neurological Disorders and is Granted FDA Breakthrough Device Designation - Business Wire - October 19th, 2022 [October 19th, 2022]
- Researcher combines AI and microelectronics to create neural implants that fight brain disorders - University of Toronto - October 19th, 2022 [October 19th, 2022]
- Global Contactless Biometrics Technology Market Size And Forecast | Aware Inc., Fingerprint Cards AB, Fujitsu Limited, Gemalto N.V., HID Global,... - October 19th, 2022 [October 19th, 2022]
- Facial Recognition Market Size and Share 2022 | Global Industry Analysis, Feasibility Study and Development Scope by 2032 | NEC Corporation (NEC)... - October 17th, 2022 [October 17th, 2022]
- Pitt scientists awarded $8 million for neurotechnology to restore arm and hand movements after strokes - University of Pittsburgh - October 15th, 2022 [October 15th, 2022]
- UN: Highlights from the 51st Session of the Human Rights Council - ARTICLE 19 - Article 19 - October 15th, 2022 [October 15th, 2022]
- PD Neurotechnology, a MedTech start-up for patients suffering from ... - October 8th, 2022 [October 8th, 2022]
- Brain ScienceConsciousness as the Property of Thought | Neurotech - VGR.com - October 6th, 2022 [October 6th, 2022]
- Facial Recognition Technology Market to witness a substantial growth owing to rising adoption of technology till 2032 | NEC Corporation, Aware,... - October 6th, 2022 [October 6th, 2022]
- ARC Future Fellowships awarded to Turner Institute researchers - Monash University - September 17th, 2022 [September 17th, 2022]
- Critics Picks: Cate Blanchett, Steven Spielberg Films Among the 15 Best of the Fall Festivals - Hollywood Reporter - September 17th, 2022 [September 17th, 2022]
- Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting - Business Wire - September 17th, 2022 [September 17th, 2022]
- If separating conjoined twins results in death, which one should die? - Big Think - September 17th, 2022 [September 17th, 2022]
- Theater of Thought Review: Werner Herzog Crafts a Bracing Exploration of Neurotechnology and Consciousness - Hollywood Reporter - September 7th, 2022 [September 7th, 2022]
- Elon Musk seeks to expand his empire in the world of neurotechnology - Gearrice - September 7th, 2022 [September 7th, 2022]
- VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimers Disease - Yahoo Finance - September 7th, 2022 [September 7th, 2022]
- Tri-anim Health Services announces exclusive relationship to distribute BrainScope's breakthrough technology for mild head injury including... - September 7th, 2022 [September 7th, 2022]
- Interaxon Inc. (Muse) Highlights Myndlifts Preliminary Study and the Benefit of Partnerships for Digital Therapeutics Research - BioSpace - September 7th, 2022 [September 7th, 2022]
- Elon Musk and Neuralink executive Shivon Zilis reportedly conceived twins via IVF - The Independent - August 29th, 2022 [August 29th, 2022]
- Biometric Wearable Market Research Insights with Trends, Competitive Analysis, Opportunities, Forecast 2022 to 2030 Muleskinner - Muleskinner - August 29th, 2022 [August 29th, 2022]
- Neurotechnology - the future of the legal profession? - Lexology - August 25th, 2022 [August 25th, 2022]
- Future criminals could be monitored by chips in their brains, experts claim... - The US Sun - August 25th, 2022 [August 25th, 2022]
- Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference - GuruFocus.com - August 25th, 2022 [August 25th, 2022]
- Investing in Brain Research and Neuroengineering - University of Houston - August 2nd, 2022 [August 2nd, 2022]
- Hamilton-based Zentrela working to understand the cannabis experience - Hamilton Spectator - August 2nd, 2022 [August 2nd, 2022]
- IntualityAI may be Able to Provide Psychotherapy for Robots in Future - AZoRobotics - August 2nd, 2022 [August 2nd, 2022]
- Coconuts, Corporations: On Vauhini Vara's The Immortal King Rao - lareviewofbooks - August 2nd, 2022 [August 2nd, 2022]
- MindMaze Enters New Strategic Partnership with Alfa Romeo F1 Team ORLEN to Advance Technologies for Brain Health, Safety, and Performance - Yahoo... - July 13th, 2022 [July 13th, 2022]
- MindMaze Receives Recognition as one of Switzerland's Best Managed Companies - Business Wire - July 13th, 2022 [July 13th, 2022]
- OpenBCI and Varjo Partner to Bring Neurotechnology to Spatial Computing - July 11th, 2022 [July 11th, 2022]
- Three top technologies taking healthcare by storm - Kalkine Media - July 11th, 2022 [July 11th, 2022]
- It is time to leverage technology to correct the challenges people have with their minds: Antano Solar, CE.. - ETHealthWorld - July 11th, 2022 [July 11th, 2022]
- Elon Musk Secretly Fathered Twins With His Company's Executive: Report - KFI AM 640 - July 11th, 2022 [July 11th, 2022]
- Stryker to host conference call on July 26, 2022 - GuruFocus.com - July 11th, 2022 [July 11th, 2022]
- Neurotechnology Announces MOSIP Integration and Support in MegaMatcher SDK and ABIS - PR Newswire - June 15th, 2022 [June 15th, 2022]
- Musk's Twitter $44 Billion Bid Includes Financier Close to Russia - Report By Investing.com - Investing.com - June 15th, 2022 [June 15th, 2022]
- Stryker Strengthens Its R&D Capabilities with Advanced Global Technology Center - Press Trust of India - Press Trust of India - June 9th, 2022 [June 9th, 2022]
- Cuba is the only nation with a governmental science and technology program on the brain - Granma English - June 9th, 2022 [June 9th, 2022]
- 3 Disruptive Tech Stocks to Go All In on Now - InvestorPlace - June 9th, 2022 [June 9th, 2022]
- OpenBCI and Varjo Partner to Bring Neurotechnology to Spatial Computing - PR Newswire - June 5th, 2022 [June 5th, 2022]
- 3D Reconstruction Technology Market Size, Scope and Forecast | 3D Reconstruction, Eos Systems Inc., Everest Innovation Technology, Microsoft, NAVVIS,... - June 5th, 2022 [June 5th, 2022]
- Fingerprint Biometrics in the VAR Market to Eyewitness Massive Growth by 2031 The Greater Binghamton Business Journal - The Greater Binghamton... - June 5th, 2022 [June 5th, 2022]
- Horrors of Elon Musks Neuralink REVEALED including brain hacking technology and animal deaths... - The Scottish Sun - May 25th, 2022 [May 25th, 2022]
- Stryker Co. (NYSE:SYK) Receives Consensus Rating of Buy from Brokerages - Defense World - May 25th, 2022 [May 25th, 2022]
- Evon Medics, LLC Has Been Awarded $2.8 Million Grant for the Development and Evaluation of its Mobile Health Platform for Remote Management of... - May 11th, 2022 [May 11th, 2022]
- Mobile Biometrics Market Analysis by Size, Business Strategies, Share, Growth, Trends, Revenue, Competitive Landscape and Developments Forecast by... - May 11th, 2022 [May 11th, 2022]
- Dubai on the Brain: NeuroVigil's Philip Low Assembles ... - May 6th, 2022 [May 6th, 2022]
- Research Associate: Participatory Research and Communications Officer job with KINGS COLLEGE LONDON | 292429 - Times Higher Education - May 6th, 2022 [May 6th, 2022]
- Face Recognition Software Market 2022: Size, Industry Share, Approaches, and Forecast By 2028, (Idemia (FR), Aware (US), Leidos (US), BioID (DE)) ... - May 6th, 2022 [May 6th, 2022]
- Stocktake: Investors wary on Musk's Twitter deal - The Irish Times - May 6th, 2022 [May 6th, 2022]
- Hydrocolloid Dressing Market Competitive Landscape Analysis With Forecast by 2027 - BioSpace - May 6th, 2022 [May 6th, 2022]
- Futuristics Overview of Neural Control Market: Industry Insights and Forecast 2022-2028 by MIT, Hebrew university, Haier, Neurotechnology,,, and more... - May 3rd, 2022 [May 3rd, 2022]
- Brain Computer Interface (BCI) Market Poised to Garner a Valuation of USD 5.48 Billion by 2030, Growing at a 14.72% CAGR - Report by Market Research... - May 3rd, 2022 [May 3rd, 2022]
- Stryker's InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery... - May 3rd, 2022 [May 3rd, 2022]
- Stryker to participate in the Bank of America Securities 2022 Health Care Conference - Benzinga - Benzinga - May 3rd, 2022 [May 3rd, 2022]
- Earnings week 2: Supply chain shortages slowed ResMed, other medtechs from meeting demand - MedTech Dive - May 3rd, 2022 [May 3rd, 2022]
- Mind-reading technology Are we ready for it? - Freethink - April 25th, 2022 [April 25th, 2022]
- The brain implant that can translate your thoughts into text - SBS News - April 15th, 2022 [April 15th, 2022]
- Stryker says 88 jobs to be eliminated in May, part of previously announced layoff schedule - The Ledger - April 15th, 2022 [April 15th, 2022]
- Moon Rabbit Collaborates with Foresight Institute to Speed Up Life Extension Research - CryptoNewsZ - April 4th, 2022 [April 4th, 2022]
- Cybin Announces Initiation of Kernel Flow Feasibility Study Measuring Psychedelic Effects on the Brain - Business Wire - April 4th, 2022 [April 4th, 2022]
- Restoring touch through electrodes implanted in the human brain will require engineering around a sensory lag - The Conversation Indonesia - March 31st, 2022 [March 31st, 2022]
- Carry On: From ketamine-assisted therapy to neurofeedback training, here's how to take a trip without leaving B.C. - BCBusiness - March 31st, 2022 [March 31st, 2022]
- Omniscient Neurotechnologys Quicktome Platform Wins 2022 ... - March 18th, 2022 [March 18th, 2022]
- Applied neuroscience needs a task force to craft effective governance - STAT - March 18th, 2022 [March 18th, 2022]
- It Can Take Weeks for Some Patients With Severe COVID to Recover Consciousness - HealthDay News - March 18th, 2022 [March 18th, 2022]